Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2025-12-24 @ 2:24 PM
NCT ID:
NCT07108959
Eligibility Criteria:
Inclusion Criteria:
* Age 30 -60 years.
* Female patients.
* ASA physical status class I - II.
* Elective resectable non metastatic breast cancer.
Exclusion Criteria:
* Patients with history of sensitivity to the studied drugs.
* Patients with cardiac conduction defects.
* Patients with major spine deformities.
* Patients with severe coagulopathy.
* Patients with infection at injection site.
* Patients with preexisting myopathy or neuropathy because it can worsen neurological deficits and increase sensitivity to local anaesthetic toxicity. Additionally, it complicates diagnosis of new symptoms and carries higher medicolegal risk due to difficulty distinguishing anaesthesia effects from disease progression.
* Psychiatric disease or seizure disorder requiring medication within the previous 2 years.
* Opioid tolerant patient.
* Cognitive dysfunction.
* Body Mass Index ( BMI ) more than 35 kg/m2 or less than 18 kg/m2 .
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
30 Years
Maximum Age:
60 Years
Study:
NCT07108959
Study Brief:
Protocol Section:
NCT07108959